Prudential Financial
KRTX

Prudential Financial’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Prudential Financial’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-13,244
Closed -$4.19M – 2786
2023
Q4 		$4.19M Buy
13,244
+5,383
+68% +$1.05M 0.01% 1024
2023
Q3 		$1.34M Sell
7,861
-5,918
-43% -$1.11M ﹤0.01% 1610
2023
Q2 		$2.99M Buy
13,779
+10,040
+269% +$2.15M ﹤0.01% 1179
2023
Q1 		$679K Buy
3,739
+105
+3% +$20.1K ﹤0.01% 1934
2022
Q4 		$714K Sell
3,634
-1,386
-28% -$297K ﹤0.01% 1861
2022
Q3 		$1.13M Sell
5,020
-2,246
-31% -$455K ﹤0.01% 1690
2022
Q2 		$918K Sell
7,266
-23,910
-77% -$2.75M ﹤0.01% 1829
2022
Q1 		$3.95M Buy
31,176
+4,158
+15% +$468K 0.01% 1102
2021
Q4 		$3.64M Buy
27,018
+15,548
+136% +$2.01M ﹤0.01% 1200
2021
Q3 		$1.39M Buy
11,470
+8,952
+356% +$1.03M ﹤0.01% 1641
2021
Q2 		$287K Buy
2,518
+652
+35% +$76.2K ﹤0.01% 2329
2021
Q1 		$224K Buy
+1,866
New +$211K ﹤0.01% 2370

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Prudential Financial's KRTX Position: Q1 2024 in Review

Prudential Financial sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 13,244 shares — an estimated $4.19M sold.

Prudential Financial first reported a position in KRTX in Q1 2021 and held it in 12 quarters. The position peaked at $4.19M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Prudential Financial reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Prudential Financial sold 13,244 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $4.19M.
  • Prudential Financial first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2021 and held it in 12 quarters.
  • Prudential Financial's Karuna Therapeutics, Inc. Common Stock position peaked at $4.19M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Prudential Financial's 13F filing for Q1 2024, filed 14 May 2024.